Literature DB >> 14563676

Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.

Paul W Harms1, Chenbei Chang.   

Abstract

Transforming growth factor beta (TGF-beta) signals regulate multiple processes during development and in adult. We recently showed that tomoregulin-1 (TMEFF1), a transmembrane protein, selectively inhibits nodal but not activin in early Xenopus embryos. Here we report that TMEFF1 binds to the nodal coreceptor Cripto, but does not associate with either nodal or the type I ALK (activin receptor-like kinase) 4 receptor in coimmunoprecipitation assays. The inhibition of the nodal signaling by TMEFF1 in Xenopus ectodermal explants is rescued with wild-type but not mutant forms of Cripto. Furthermore, we show that the Cripto-FRL1-Cryptic (CFC) domain in Cripto, which is essential for its binding to ALK4, is also important for its interaction with TMEFF1. Our results demonstrate for the first time that nodal signaling can be regulated by a novel mechanism of blocking the Cripto coreceptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563676      PMCID: PMC280611          DOI: 10.1101/gad.1127703

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  39 in total

1.  Nodal activity in the node governs left-right asymmetry.

Authors:  Jane Brennan; Dominic P Norris; Elizabeth J Robertson
Journal:  Genes Dev       Date:  2002-09-15       Impact factor: 11.361

2.  Ectopic dendrite initiation: CNS pathogenesis as a model of CNS development.

Authors:  Donald A Siegel; May K Huang; Shannon F Becker
Journal:  Int J Dev Neurosci       Date:  2002 Jun-Aug       Impact factor: 2.457

3.  TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells.

Authors:  Sigal Gery; Charles L Sawyers; David B Agus; Jonathan W Said; H Phillip Koeffler
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

4.  Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.

Authors:  Caterina Bianco; Heather B Adkins; Christian Wechselberger; Masaharu Seno; Nicola Normanno; Antonella De Luca; Youping Sun; Nadia Khan; Nicholas Kenney; Andreas Ebert; Kevin P Williams; Michele Sanicola; David S Salomon
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion.

Authors:  Rui Sakuma; Yu-ichiro Ohnishi Yi; Chikara Meno; Hideta Fujii; Hou Juan; Jun Takeuchi; Toshihiko Ogura; En Li; Kohei Miyazono; Hiroshi Hamada
Journal:  Genes Cells       Date:  2002-04       Impact factor: 1.891

Review 6.  Cripto: a tumor growth factor and more.

Authors:  Eileen D Adamson; Gabriella Minchiotti; David S Salomon
Journal:  J Cell Physiol       Date:  2002-03       Impact factor: 6.384

7.  Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.

Authors:  Yu-Ting Yan; Jan-Jan Liu; Yi Luo; Chaosu E; Robert S Haltiwanger; Cory Abate-Shen; Michael M Shen
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1.

Authors:  Simon K Cheng; Felix Olale; James T Bennett; Ali H Brivanlou; Alexander F Schier
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

9.  Effects of heterodimerization and proteolytic processing on Derrière and Nodal activity: implications for mesoderm induction in Xenopus.

Authors:  Peter M Eimon; Richard M Harland
Journal:  Development       Date:  2002-07       Impact factor: 6.868

10.  The Foxh1-dependent autoregulatory enhancer controls the level of Nodal signals in the mouse embryo.

Authors:  Dominic P Norris; Jane Brennan; Elizabeth K Bikoff; Elizabeth J Robertson
Journal:  Development       Date:  2002-07       Impact factor: 6.868

View more
  22 in total

Review 1.  Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.

Authors:  Nicholas J Kenney; Heather B Adkins; Michele Sanicola
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

2.  Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.

Authors:  Christof Haffner; Mélanie Frauli; Stephanie Topp; Martin Irmler; Kay Hofmann; Jörg T Regula; Laure Bally-Cuif; Christian Haass
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 3.  The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.

Authors:  Malgorzata Klauzinska; Nadia P Castro; Maria Cristina Rangel; Benjamin T Spike; Peter C Gray; Daniel Bertolette; Frank Cuttitta; David Salomon
Journal:  Semin Cancer Biol       Date:  2014-08-19       Impact factor: 15.707

4.  A role for Vg1/Nodal signaling in specification of the intermediate mesoderm.

Authors:  Britannia M Fleming; Ronit Yelin; Richard G James; Thomas M Schultheiss
Journal:  Development       Date:  2013-04       Impact factor: 6.868

Review 5.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

6.  Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.

Authors:  Peter C Gray; Gidi Shani; Kevin Aung; Jonathan Kelber; Wylie Vale
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

7.  Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention.

Authors:  Luigi Strizzi; Lynne-Marie Postovit; Naira V Margaryan; Alina Lipavsky; Jules Gadiot; Christian Blank; Richard Eb Seftor; Elisabeth A Seftor; Mary Jc Hendrix
Journal:  Expert Rev Dermatol       Date:  2009

8.  Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.

Authors:  J A Kelber; A D Panopoulos; G Shani; E C Booker; J C Belmonte; W W Vale; P C Gray
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

9.  Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer.

Authors:  Joshua M Corbin; Ryan F Overcash; Jonathan D Wren; Anita Coburn; Greg J Tipton; Jennifer A Ezzell; Kirk K McNaughton; Kar-Ming Fung; Stanley D Kosanke; Maria J Ruiz-Echevarria
Journal:  Prostate       Date:  2015-09-29       Impact factor: 4.104

10.  Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.

Authors:  Luigi Strizzi; Daniel E Abbott; David S Salomon; Mary J C Hendrix
Journal:  Cell Cycle       Date:  2008-05-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.